A systematic review and meta-analysis of nab-paclitaxel mono-chemotherapy for metastatic breast cancer

BACKGROUND: Although various clinical trials and real-life studies have tried to explore the value of nab-paclitaxel mono-chemotherapy for metastatic breast cancer (MBC), the safety and efficacy of nab-paclitaxel remain unclear which need to be systematically evaluated. METHODS: Electronic searches...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Haili, Zha, Siluo, Zhang, Wei, Wang, Qiang, Jiang, Daozhen, Xu, Xinyun, Zheng, Xiangmin, Qiu, Ming, Shan, Chengxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286600/
https://www.ncbi.nlm.nih.gov/pubmed/34275458
http://dx.doi.org/10.1186/s12885-021-08441-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286600/
https://www.ncbi.nlm.nih.gov/pubmed/34275458
http://dx.doi.org/10.1186/s12885-021-08441-z

Ejemplares similares